Palazzo, M., Shah, G. L., Copelan, O., Seier, K., Devlin, S. M., Maloy, M., . . . Perales, M. (2017). Re-vaccination following Autologous Hematopoietic Stem Cell Transplantation is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance. Biol Blood Marrow Transplant.
Style de citation ChicagoPalazzo, Meighan, et al. "Re-vaccination Following Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients With Multiple Myeloma Receiving Lenalidomide Maintenance." Biol Blood Marrow Transplant 2017.
Style de citation MLAPalazzo, Meighan, et al. "Re-vaccination Following Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients With Multiple Myeloma Receiving Lenalidomide Maintenance." Biol Blood Marrow Transplant 2017.